The role of targeted MRI-ultrasound fusion biopsies of the prostate in patients suspected for prostate cancer

The role of targeted MRI-ultrasound fusion biopsies of the prostate in patients suspected for prostate cancer - ProMES study (prostate biopsies using MR-Ultrasound fusion study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44626

Enrollment

350

Registered

2017-12-19

Start date

2018-01-26

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant neoplasm of the prostate Prostate cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age>18 years, - Indication for undergoing prostate biopsies - Written informed consent

Exclusion criteria

Exclusion criteria: - Patients who are suspected in advance to have bone metastases - Patient not able to undergo MRI

Design outcomes

Primary

Measure	Time frame
All found prostate cancers	—

Secondary

Measure	Time frame
Classification of the found prostate cancers The amount of patients eligible for Active Surveillance	—

Countries

Netherlands

Outcome results